Interleukin-21 receptor gene polymorphism is associated with hepatitis B virus-related hepatocellular carcinoma in Chinese patients

Tangyuheng Liu; Mei Zhang; Jiajia Song; Siyue Li; Jinya Zhang; Xuejiao Hu; Zhenzhen Zhao; Wu Peng; Qian Wu; Hao Bai; Yinyu Li; Xiaojun Lu; Binwu Ying

doi:10.18632/oncotarget.24053

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Interleukin-21 receptor gene polymorphism is associated with hepatitis B virus-related hepatocellular carcinoma in Chinese patients

Tangyuheng Liu, Mei Zhang, Jiajia Song, Siyue Li, Jinya Zhang, Xuejiao Hu, Zhenzhen Zhao, Wu Peng, Qian Wu, Hao Bai, Yinyu Li, Xiaojun Lu _ and Binwu Ying

Tangyuheng Liu1,*, Mei Zhang1,*, Jiajia Song1,*, Siyue Li1,*, Jinya Zhang1, Xuejiao Hu1, Zhenzhen Zhao1, Wu Peng1, Qian Wu1, Hao Bai1, Yinyu Li2, Xiaojun Lu1 and Binwu Ying1

1Department of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan Province, P. R. China

2Department of Laboratory Medicine, Affiliated Hospital of Chengdu University, Sichuan Province, P. R. China

*These authors have contributed equally to this work

Correspondence to:

Xiaojun Lu, email: [email protected]

Binwu Ying, email: [email protected]

Keywords: HBV; IL-21; IL-21R; JAK/STAT; SNP

Received: April 26, 2017 Accepted: December 27, 2017 Epub: January 02, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24053

Publication Alerts

Withdrawal Notice

Research Papers:

Interleukin-21 receptor gene polymorphism is associated with hepatitis B virus-related hepatocellular carcinoma in Chinese patients